Global High Throughput Screening (HTS) Market to Reach $45.3 Billion by 2030
The global market for High Throughput Screening (HTS) estimated at US$40 Billion in the year 2022, is projected to reach a revised size of US$45.3 Billion by 2030, growing at a CAGR of 1.6% over the analysis period 2022-2030. Consumables / Reagents, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$16.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised -4.5% CAGR for the next 8-year period.The U.S. Market is Estimated at $11.2 Billion, While China is Forecast to Grow at 6.9% CAGR
The High Throughput Screening (HTS) market in the U.S. is estimated at US$11.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$11.3 Billion by the year 2030 trailing a CAGR of 6.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -6.9% and -4.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately -5.7% CAGR.Select Competitors (Total 41 Featured) -
- Agilent Technologies, Inc.
- Aurora Biomed Inc.
- Axxam SpA
- BD Biosciences
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- BioTek Instruments Inc.
- BMG LABTECH GmbH
- Charles River Laboratories International Inc.
- Corning Inc.
- Danaher Corporation
- Evotec AG
- F. Hoffmann-La Roche Ltd.
- Genedata AG
- IntelliCyt® Corporation
- Luminex Corporation
- Molecular Devices Inc.
- Pall ForteBio LLC
- PerkinElmer Inc.
- Sigma-Aldrich Corp.
- Tecan Group Ltd.
- Thermo Fischer Scientific Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARYIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies, Inc.
- Aurora Biomed Inc.
- Axxam SpA
- BD Biosciences
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- BioTek Instruments Inc.
- BMG LABTECH GmbH
- Charles River Laboratories International Inc.
- Corning Inc.
- Danaher Corporation
- Evotec AG
- F. Hoffmann-La Roche Ltd.
- Genedata AG
- IntelliCyt® Corporation
- Luminex Corporation
- Molecular Devices Inc.
- Pall ForteBio LLC
- PerkinElmer Inc.
- Sigma-Aldrich Corp.
- Tecan Group Ltd.
- Thermo Fischer Scientific Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 273 |
Published | May 2024 |
Forecast Period | 2020 - 2027 |
Estimated Market Value ( USD | $ 31 Billion |
Forecasted Market Value ( USD | $ 50.1 Billion |
Compound Annual Growth Rate | 7.1% |
Regions Covered | Global |